ProScript, HMR deal

The companies amended their November 1995 agreement to develop ProScript's small molecule proteasome inhibitors and

Read the full 155 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE